April Kloxin is part of an ever-growing body of researchers and clinicians making it their mission to outsmart breast cancer cells.

Kloxin, a University of Delaware engineering professor and Pew Scholar in Biomedical Science, wants to know why 20 percent of women who are treated and declared breast cancer-free by their doctors develop breast cancer five to 25 years later. When cancer strikes again, it metastasizes in other parts of the body such as the bones and lungs.

She has been awarded a $450,000 grant from Susan G. Komen – one of the largest grants awarded to Delaware researchers in the past 20 years – to find out why breast cancer cells stay quiet in the body for years after treatment and what makes them reawaken. Read more at Delaware Online.